ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF

Molecular and Cellular Biology

Volumn 33, Issue 2, 2013, Pages 265-280

  Chandler, Ronald L ^a   Brennan, Jennifer ^a   Schisler, Jonathan C ^a   Serber, Daniel ^a   Patterson, Cam ^a   Magnuson, Terry ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARID1 PROTEIN; DNA BINDING PROTEIN; SMALL INTERFERING RNA; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA BINDING MOTIF; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; GENOTYPING TECHNIQUE; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPORTER GENE; SWI SNF COMPLEX;

EUKARYOTA; MUS;

EID: 84871867133     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01008-12     Document Type: Article

References (74)

1. Weintraub H, Groudine M. 1976. Chromosomal subunits in active genes have an altered conformation. Science 193:848-856.
2. Neigeborn L, Carlson M. 1984. Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae. Genetics 108:845- 858.
3. Stern M, Jensen R, Herskowitz I. 1984. Five SWI genes are required for expression of the HO gene in yeast. J. Mol. Biol. 178:853- 868.
4. Cairns BR, Kim YJ, Sayre MH, Laurent BC, Kornberg RD. 1994. A multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNF5, and SNF6 gene products isolated from yeast. Proc. Natl. Acad. Sci. U. S. A. 91:1950 -1954.
5. Cote J, Quinn J, Workman JL, Peterson CL. 1994. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265:53- 60
6. Peterson CL, Dingwall A, Scott MP. 1994. Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc. Natl. Acad. Sci. U. S. A. 91:2905-2908.
7. Bourachot B, Yaniv M, Muchardt C. 1999. The activity of mammalian brm/SNF2α is dependent on a high-mobility-group protein I/Y-likeDNA binding domain. Mol. Cell. Biol. 19:3931-3939.
8. Collins RT, Furukawa T, Tanese N, Treisman JE. 1999. Osa associates with the Brahma chromatin remodeling complex and promotes the activation of some target genes. EMBO J. 18:7029 -7040.
9. Cote J, Peterson CL, Workman JL. 1998. Perturbation of nucleosome core structure by the SWI/SNF complex persists after its detachment, enhancing subsequent transcription factor binding. Proc. Natl. Acad. Sci. U. S. A. 95:4947- 4952.
10. Patsialou A, Wilsker D, Moran E. 2005. DNA-binding properties of ARID family proteins. Nucleic Acids Res. 33:66-80.
11. Quinn J, Fyrberg AM, Ganster RW, Schmidt MC, Peterson CL. 1996. DNA-binding properties of the yeast SWI/SNF complex. Nature 379:844- 847.
12. Singh M, D'Silva L, Holak TA. 2006. DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein. Biol. Chem. 387:1469 -1478.
13. Wang W, Chi T, Xue Y, Zhou S, Kuo A, Crabtree GR. 1998. Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc. Natl. Acad. Sci. U. S. A. 95:492- 498.
14. Wilsker D, Patsialou A, Zumbrun SD, Kim S, Chen Y, Dallas PB, Moran E. 2004. The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexes. Nucleic Acids Res. 32:1345-1353.
15. Sudarsanam P, Winston F. 2000. The Swi/Snf family nucleosomeremodeling complexes and transcriptional control. Trends Genet. 16: 345-351.
16. Dallas PB, Pacchione S, Wilsker D, Bowrin V, Kobayashi R, Moran E. 2000. The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol. Cell. Biol. 20:3137-3146.
17. Inoue H, Furukawa T, Giannakopoulos S, Zhou S, King DS, Tanese N. 2002. Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors. J. Biol. Chem. 277:41674-41685.
18. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, AN W, Takeuchi T, Ohtsuki Y, Sugano S, de Bruijn DR, Chait BT, Roeder RG. 2002. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J. Biol. Chem. 277:5498 -5505.
19. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W. 2000. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol. Cell. Biol. 20:8879-8888.
20. Nie Z, Yan Z, Chen EH, Sechi S, Ling C, Zhou S, Xue Y, Yang D, Murray D, Kanakubo E, Cleary ML, Wang W. 2003. Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol. Cell. Biol. 23:2942-2952.
21. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K, Wang W. 2005. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferonresponsive genes. Genes Dev. 19:1662-1667.
22. Nagl NG, Jr, Wang X, Patsialou A, Van Scoy M, Moran E. 2007. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J. 26:752-763.
23. Gao X, Tate P, Hu P, Tjian R, Skarnes WC, Wang Z. 2008. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc. Natl. Acad. Sci. U. S. A. 105: 6656-6661.
24. Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA, Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N. 2010. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330:228 -231.
25. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih Ie M, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG. 2010. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363:1532-1543.
26. Chen Y, Vivian JL, Magnuson T. 2003. Gene-based chemical mutagenesis in mouse embryonic stem cells. Methods Enzymol. 365:406-415.
27. Chen Y, Yee D, Dains K, Chatterjee A, Cavalcoli J, Schneider E, Om J, Woychik RP, Magnuson T. 2000. Genotype-based screen for ENUinduced mutations in mouse embryonic stem cells. Nat. Genet. 24:314- 317.
28. Aaronson SA, Todaro GJ. 1968. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J. Cell. Physiol. 72:141-148.
29. Aaronson SA, Todaro GJ. 1968. SV40 T antigen induction and transformation in human fibroblast cell strains. Virology 36:254 -261.
30. Gregory SL, Kortschak RD, Kalionis B, Saint R. 1996. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence- specific DNA-binding proteins. Mol. Cell. Biol. 16:792-799.
31. Smith DB, Johnson KS. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31- 40.
32. Iwahara J, Iwahara M, Daughdrill GW, Ford J, Clubb RT. 2002. The structure of the Dead ringer-DNA complex reveals how AT-rich interaction domains (ARIDs) recognize DNA. EMBO J. 21:1197-1209.
33. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
34. Li YC, Ross J, Scheppler JA, Franza BR, Jr. 1991. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Mol. Cell. Biol. 11:1883-1893.
35. Chi T, Yan Z, Xue Y, Wang W. 2004. Purification and functional analysis of the mammalian SWI/SNF-family of chromatin-remodeling complexes. Methods Enzymol. 377:299 -316.
36. Fan HY, He X, Kingston RE, Narlikar GJ. 2003. Distinct strategies to make nucleosomal DNA accessible. Mol. Cell 11:1311-1322.
37. Sif S, Saurin AJ, Imbalzano AN, Kingston RE. 2001. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15:603- 618.
38. Duband-Goulet I, Ouararhni K, Hamiche A. 2004. Methods for chromatin assembly and remodeling. Methods 33:12-17.
39. Stein A, Whitlock JP, Jr, Bina M. 1979. Acidic polypeptides can assemble both histones and chromatin in vitro at physiological ionic strength. Proc. Natl. Acad. Sci. U. S. A. 76:5000 -5004.
40. Solomon MJ, Larsen PL, Varshavsky A. 1988. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937-947.
41. Nelson JD, Denisenko O, Bomsztyk K. 2006. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1:179 -185.
42. Chandler RL, Chandler KJ, McFarland KA, Mortlock DP. 2007. Bmp2 transcription in osteoblast progenitors is regulated by a distant 3" enhancer located 156.3 kilobases from the promoter. Mol. Cell. Biol. 27: 2934-2951.
43. Screen M, Dean W, Cross JC, Hemberger M. 2008. Cathepsin proteases have distinct roles in trophoblast function and vascular remodelling. Development 135:3311-3320.
44. Griffin CT, Brennan J, Magnuson T. 2008. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 135:493-500.
45. Shingu T, Bornstein P. 1994. Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J. Biol. Chem. 269:32551-32557.
46. Tropsha A, Carter CW, Jr, Cammer S, Vaisman II. 2003. Simplicial neighborhood analysis of protein packing (SNAPP): a computational geometry approach to studying proteins. Methods Enzymol. 374:509 -544.
47. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. 2004. VISTA: computational tools for comparative genomics. Nucleic Acids Res. 32: W273-W279.
48. Chen Y, Yee D, Magnuson T. 2006. A novel mouse Smad4 mutation reduces protein stability and wild-type protein levels. Mamm. Genome. 17:211-219.
49. Lei I, Gao X, Sham MH, Wang Z. 2012. SWI/SNF Protein component BAF250a regulates cardiac progenitor cell differentiation by modulating chromatin accessibility during second heart field development. J. Biol. Chem. 287:24255-24262.
50. Copp AJ. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87-93.
51. Griffin CT, Curtis CD, Davis RB, Muthukumar V, Magnuson T. 2011. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc. Natl. Acad. Sci. U. S. A. 108:2282-2287.
52. Inoue H, Giannakopoulos S, Parkhurst CN, Matsumura T, Kono EA, Furukawa T, Tanese N. 2011. Target genes of the largest human SWI/SNF complex subunit control cell growth. Biochem. J. 434:83-92.
53. Prochasson P, Neely KE, Hassan AH, Li B, Workman JL. 2003. Targeting activity is required for SWI/SNF function in vivo and is accomplished through two partially redundant activator-interaction domains. Mol. Cell 12:983-990.
54. Li XS, Trojer P, Matsumura T, Treisman JE, Tanese N. 2010. Mammalian SWI/SNF-a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol. Cell. Biol. 30:1673-1688.
55. Kortschak RD, Tucker PW, Saint R. 2000. ARID proteins come in from the desert. Trends Biochem. Sci. 25:294 -299.
56. Carter CW, Jr, LeFebvre BC, Cammer SA, Tropsha A, Edgell MH. 2001. Four-body potentials reveal protein-specific correlations to stability changes caused by hydrophobic core mutations. J. Mol. Biol. 311:625- 638.
57. Krishnamoorthy B, Tropsha A. 2003. Development of a four-body statistical pseudo-potential to discriminate native from non-native protein conformations. Bioinformatics 19:1540 -1548.
58. Sherman DB, Zhang S, Pitner JB, Tropsha A. 2004. Evaluation of the relative stability of liganded versus ligand-free protein conformations using simplicial neighborhood analysis of protein packing (SNAPP) method. Proteins 56:828-838.
59. Kim S, Zhang Z, Upchurch S, Isern N, Chen Y. 2004. Structure and DNA-binding sites of the SWI1 AT-rich interaction domain (ARID) suggest determinants for sequence-specific DNA recognition. J. Biol. Chem. 279:16670 -16676.
60. Wu JI, Lessard J, Crabtree GR. 2009. Understanding the words of chromatin regulation. Cell 136:200 -206.
61. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, El-Osta A. 2005. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet. 37:254 -264.
62. Park SW, Li G, Lin YP, Barrero MJ, Ge K, Roeder RG, Wei LN. 2005. Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. Mol. Cell 19:643- 653.
63. Stankunas K, Hang CT, Tsun ZY, Chen H, Lee NV, Wu JI, Shang C, Bayle JH, Shou W, Iruela-Arispe ML, Chang CP. 2008. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev. Cell 14:298 -311.
64. Fouladkou F, Lu C, Jiang C, Zhou L, She Y, Walls JR, Kawabe H, Brose N, Henkelman RM, Huang A, Bruneau BG, Rotin D. The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of thrombospondin-1. J. Biol. Chem. 285:6770-6780.
65. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM. 2002. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2:473- 483.
66. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P, Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA. 2012. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603- 607.
67. Kaplan MH, Zong RT, Herrscher RF, Scheuermann RH, Tucker PW. 2001. Transcriptional activation by a matrix associating region-binding protein. contextual requirements for the function of bright. J. Biol. Chem. 276:21325-21330.
68. Kobayashi S, Eden-McCutchan F, Framson P, Bornstein P. 1986. Partial amino acid sequence of human thrombospondin as determined by analysis of cDNA clones: homology to malarial circumsporozoite proteins. Biochemistry 25:8418-8425.
69. Majack RA, Mildbrandt J, Dixit VM. 1987. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J. Biol. Chem. 262:8821- 8825.
70. Rafati H, Parra M, Hakre S, Moshkin Y, Verdin E, Mahmoudi T. 2011. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency. PLoS Biol. 9:e1001206. doi:10.1371/ journal.pbio.1001206.
71. Brown SA, Imbalzano AN, Kingston RE. 1996. Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev. 10:1479 -1490.
72. Wilson CJ, Chao DM, Imbalzano AN, Schnitzler GR, Kingston RE, Young RA. 1996. RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell 84:235-244.
73. Hassan AH, Prochasson P, Neely KE, Galasinski SC, Chandy M, Carrozza MJ, Workman JL. 2002. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111:369 -379.
74. Chatterjee N, Sinha D, Lemma-Dechassa M, Tan S, Shogren-Knaak MA, Bartholomew B. 2011. Histone H3 tail acetylation modulates ATPdependent remodeling through multiple mechanisms. Nucleic Acids Res. 39:8378-8391.